Find a Clinical Trial

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)

A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer (VOLGA)

18+

Learn more

ROACTIVE-HF II

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)

18+

Learn more

Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer

Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer

18-90

Learn more

OCS Heart Perfusion Registry

OCS Heart Perfusion Post- Approval Registry

18+

Learn more

Pulmonary vascular impedance in cardiogenic shock

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

18+

Learn more